This company has been marked as potentially delisted and may not be actively trading.

Soleno Therapeutics (SLNO) Insider Trading & Ownership

Current Insider Ownership Percentage: 6.40%
Number Of Insiders Buying (Last 3 Years): 1
Amount Of Insider Buying (Last 3 Years): $15.12M
Number Of Insiders Selling (Last 3 Years): 9
Amount Of Insider Selling (Last 3 Years): $147.65M

Get SLNO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Soleno Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SLNO Insider Buying and Selling by Quarter

Soleno Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export

Transaction Date	Insider	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/1/2025	Patricia C Hirano Insider	Sell	3,830	$82.76	$316,970.80
6/24/2025	Patricia C Hirano Insider	Sell	266	$84.25	$22,410.50
4/1/2025	Patricia C Hirano Insider	Sell	3,782	$70.11	$265,156.02
3/28/2025	Matthew Pauls Director	Sell	5,937	$71.55	$424,792.35
3/27/2025	Bhatnagar Anish CEO	Sell	699,095	$67.62	$47,272,803.90
3/27/2025	James H Mackaness CFO	Sell	90,622	$69.44	$6,292,791.68
3/27/2025	Michael F Huang VP	Sell	14,583	$69.51	$1,013,664.33
3/27/2025	Patricia C Hirano Insider	Sell	128,653	$68.32	$8,789,572.96
1/3/2025	Kristen Yen Insider	Sell	2,340	$46.18	$108,061.20
1/2/2025	Bhatnagar Anish CEO	Sell	10,937	$45.41	$496,649.17
Get Insider Trades Delivered To Your Inbox Enter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings.
1/2/2025	James H Mackaness CFO	Sell	4,083	$45.41	$185,409.03
10/1/2024	Bhatnagar Anish CEO	Sell	21,633	$49.43	$1,069,319.19
10/1/2024	James H Mackaness CFO	Sell	8,077	$49.43	$399,246.11
10/1/2024	Kristen Yen Insider	Sell	3,108	$49.43	$153,628.44
8/29/2024	Vivo Opportunity, Llc Major Shareholder	Sell	100,000	$47.22	$4,722,000.00
8/28/2024	Bhatnagar Anish CEO	Sell	56,613	$47.58	$2,693,646.54
8/28/2024	James H Mackaness CFO	Sell	6,661	$47.58	$316,930.38
8/28/2024	Kristen Yen Insider	Sell	5,270	$47.58	$250,746.60
8/27/2024	Vivo Opportunity, Llc Major Shareholder	Sell	500,000	$48.73	$24,365,000.00
8/5/2024	Bhatnagar Anish CEO	Sell	58,213	$45.77	$2,664,409.01
8/5/2024	James H Mackaness CFO	Sell	6,849	$45.77	$313,478.73
8/5/2024	Kristen Yen Insider	Sell	5,017	$45.77	$229,628.09
7/1/2024	Bhatnagar Anish CEO	Sell	19,256	$41.54	$799,894.24
7/1/2024	James H Mackaness CFO	Sell	7,190	$41.54	$298,672.60
7/1/2024	Kristen Yen Insider	Sell	2,170	$41.54	$90,141.80
4/29/2024	Vivo Opportunity, Llc Major Shareholder	Sell	750,000	$47.80	$35,850,000.00
4/1/2024	Bhatnagar Anish CEO	Sell	18,980	$41.34	$784,633.20
4/1/2024	James H Mackaness CFO	Sell	5,175	$41.34	$213,934.50
4/1/2024	Kristen Yen Insider	Sell	2,218	$41.34	$91,692.12
1/25/2024	Bhatnagar Anish CEO	Sell	2,527	$48.30	$122,054.10
1/25/2024	Kristen Yen Insider	Sell	397	$48.30	$19,175.10
12/13/2023	Kristen Yen Insider	Sell	17,916	$37.76	$676,508.16
12/11/2023	Bhatnagar Anish CEO	Sell	93,408	$35.67	$3,331,863.36
12/11/2023	James H Mackaness CFO	Sell	32,482	$36.41	$1,182,669.62
11/30/2023	Bhatnagar Anish CEO	Sell	27,716	$28.65	$794,063.40
11/30/2023	James H Mackaness CFO	Sell	4,186	$28.65	$119,928.90
11/29/2023	Kristen Yen Insider	Sell	3,979	$27.83	$110,735.57
11/28/2023	Bhatnagar Anish CEO	Sell	25,678	$27.12	$696,387.36
11/28/2023	James H Mackaness CFO	Sell	3,878	$27.12	$105,171.36
9/28/2023	Perceptive Advisors Llc Major Shareholder	Buy	250,000	$20.00	$5,000,000.00
America’s answer to universal basic income (Ad) Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income Plan - direct ownership in 14 entities controlling U.S. pipelines, terminals, and processing plants, targeting 10% annually. The plan issues 42 payouts per year and is on pace to distribute $53 billion in 2025 - a record. The next distribution drops in days. See how to enroll in the Patriot Income Plan before the next payout
9/26/2023	Perceptive Advisors Llc Major Shareholder	Buy	616,789	$16.40	$10,115,339.60

(Data available from 1/1/2013 forward)

SLNO Insider Trading Activity - Frequently Asked Questions

The list of insiders at Soleno Therapeutics includes Bhatnagar Anish, James H Mackaness, Kristen Yen, Matthew Pauls, Michael F Huang, Patricia C Hirano, Perceptive Advisors Llc, and Vivo Opportunity, Llc. Learn more on insiders at SLNO.

6.40% of Soleno Therapeutics stock is owned by insiders. Learn more on SLNO's insider holdings.

The following insiders have sold SLNO shares in the last 24 months: Bhatnagar Anish ($54,196,827.81), James H Mackaness ($7,507,855.93), Kristen Yen ($742,064.33), Matthew Pauls ($424,792.35), Michael F Huang ($1,013,664.33), Patricia C Hirano ($9,394,110.28), and Vivo Opportunity, Llc ($29,087,000.00).

Insiders have sold a total of 1,735,569 Soleno Therapeutics shares in the last 24 months for a total of $102,366,315.03 sold.

Soleno Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

Related Companies

Insider Tracking Tools

Insider Trading By Country

Latest Articles

This page (NASDAQ:SLNO) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Soleno Therapeutics (SLNO) Insider Trading & Ownership

SLNO Insider Buying and Selling by Quarter

Soleno Therapeutics Insider and Congressional Trades History

SLNO Insider Trading Activity - Frequently Asked Questions

Soleno Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Soleno Therapeutics (SLNO) Insider Trading & Ownership

Soleno Therapeutics (NASDAQ:SLNO) Insider Buying and Selling Activity

SLNO Insider Buying and Selling by Quarter

Soleno Therapeutics Insider and Congressional Trades History

SLNO Insider Trading Activity - Frequently Asked Questions

Who is on Soleno Therapeutics' Insider Roster?

What percentage of Soleno Therapeutics stock is owned by insiders?

Which Soleno Therapeutics insiders have been selling company stock?

How much insider selling is happening at Soleno Therapeutics?

Soleno Therapeutics Active Insiders

More Insider Trading Tools from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools